Masterson Richard Kevin 4/A
4/A · Valeant Pharmaceuticals International, Inc. · Filed Oct 27, 2011
Insider Transaction Report
Form 4/AAmended
Masterson Richard Kevin
Pres.&COO, Valeant Int.(BB)SRL
Transactions
- Award
Common Shares, no par value
2011-10-24+10,282→ 85,422 total
Footnotes (4)
- [F1]Represents Restricted Share Units received under an employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- [F2]1/3 of the Matching RSUs will vest each on the first, second and third anniversary of the date of grant subject to contingent employment and retention of the corresponding purchased shares.
- [F3]Previously reported 9,900 shares, but acquired was 10,282 shares.
- [F4]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.